These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23058227)

  • 1. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
    Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
    Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
    Jeong JW; Jung SJ; Lee HH; Kim YZ; Park TK; Cho YL; Chae SE; Baek SY; Woo SH; Lee HS; Kwak JH
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5359-62. PubMed ID: 20855730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
    Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus.
    Oh SH; Park HS; Lee JH; Baek SY; Chae SE; Oh K; Cho YL; Kwak JH
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186032
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of varied substituents on the antibacterial activity of triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Arch Pharm (Weinheim); 2012 Oct; 345(10):790-803. PubMed ID: 22886578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.
    Park HS; Yoon YM; Jung SJ; Kim CM; Kim JM; Kwak JH
    J Antimicrob Chemother; 2007 Sep; 60(3):568-74. PubMed ID: 17606482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of YC-20, a new oxazolidinone.
    Cui Y; Dang Y; Yang Y; Zhang S; Ji R
    J Antimicrob Chemother; 2006 Aug; 58(2):452-4. PubMed ID: 16807251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
    Jones RN; Ross JE; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2006 Feb; 57(2):279-87. PubMed ID: 16326811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
    Rolston KV; Kapadia M; Tarrand J; Coyle E; Prince RA
    Int J Antimicrob Agents; 2013 Jun; 41(6):516-20. PubMed ID: 23481658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
    Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):300-4. PubMed ID: 19501791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.
    Mutnick AH; Biedenbach DJ; Turnidge JD; Jones RN
    Diagn Microbiol Infect Dis; 2002 May; 43(1):65-73. PubMed ID: 12052631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
    Schwameis R; Fille M; Manafi M; Zeitlinger M; Sauermann R
    Res Microbiol; 2012 Apr; 163(3):157-60. PubMed ID: 22210435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.